Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Adenoma and CDKN1B[original query] |
---|
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. The Journal of clinical endocrinology and metabolism 2007 Aug 92 (8): 3321-5. Georgitsi Marianthi, Raitila Anniina, Karhu Auli, van der Luijt Rob B, Aalfs Cora M, Sane Timo, Vierimaa Outi, Mäkinen Markus J, Tuppurainen Karoliina, Paschke Ralph, Gimm Oliver, Koch Christian A, Gündogdu Sadi, Lucassen Anneke, Tischkowitz Marc, Izatt Louise, Aylwin Simon, Bano Gul, Hodgson Shirley, De Menis Ernesto, Launonen Virpi, Vahteristo Pia, Aaltonen Lauri |
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations. Clinical endocrinology 2009 Feb 70 (2): 259-64. Igreja Susana, Chahal Harvinder S, Akker Scott A, Gueorguiev Maria, Popovic Vera, Damjanovic Svetozar, Burman Pia, Wass John A, Quinton Richard, Grossman Ashley B, Korbonits Már |
Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition. Journal of endocrinological investigation 2009 Jun 32 (6): 512-8. Vierimaa O, Villablanca A, Alimov A, Georgitsi M, Raitila A, Vahteristo P, Larsson C, Ruokonen A, Eloranta E, Ebeling T M L, Ignatius J, Aaltonen L A, Leisti J, Salmela P |
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. European journal of endocrinology / European Federation of Endocrine Societies 2010 Sep 163 (3): 369-76. Occhi G, Trivellin G, Ceccato F, De Lazzari P, Giorgi G, Demattè S, Grimaldi F, Castello R, Davì M V, Arnaldi G, Salviati L, Opocher G, Mantero F, Scaroni |
Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas. Hormones & cancer 2013 Oct 4 (5): 301-7. Costa-Guda Jessica, Soong Chen-Pang, Parekh Vaishali I, Agarwal Sunita K, Arnold Andr |
Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer. Oncology letters 2018 9 16 (4): 5275-5281. Ohuchi Mayuko, Sakamoto Yasuo, Tokunaga Ryuma, Kiyozumi Yuki, Nakamura Kenichi, Izumi Daisuke, Kosumi Keisuke, Harada Kazuto, Kurashige Junji, Iwatsuki Masaaki, Baba Yoshifumi, Miyamoto Yuji, Yoshida Naoya, Shono Takashi, Naoe Hideaki, Sasaki Yutaka, Baba Hid |
Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome? Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021 7 166 (2): 228-235. Dolina Jiri, Kunovsky Lumir, Kroupa Radek, Stary Karel, Jabandziev Petr, Nesporova Tereza, Maca Karel, Andrasina Tomas, Marek Filip, Kala Zdenek, Vaculova Jitka, Said David, Zapletalova Martina, Lochman Jan, Palova Noskova Hana, Slaby Ondrej, Izakovicova Holla Lydie, Borilova Linhartova Pet |
Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2021 4 53 (4): 245-256. Shyamasunder Asha Hesarghatta, Pai Rekha, Ramamoorthy Hemalatha, Sakhti Dhananjayan, Manipadam Marie Therese, Kapoor Nitin, Paul Thomas Vizhalil, Jebasingh Felix, Thomas Nihal, Abraham Deepak Thomas, Paul Mazhuvanchary Jacob, Chacko Ari George, Prabhu Krishna, Rajaratnam Sim |
[MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022]. La Revue de medecine interne 2022 10 44 (1): 12-18. Duval M, Haissaguerre |
Germline CDKN1B variant type and site are associated with phenotype in MEN4. Endocrine-related cancer 2022 10 30 (1): . Halperin Reut, Arnon Liat, Nasirov Sapir, Friedensohn Limor, Gershinsky Michal, Telerman Alona, Friedman Eitan, Bernstein-Molho Rinat, Tirosh Am |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: